Novavax Q2 2024 GAAP EPS $0.99 Misses $1.64 Estimate, Sales $415.484M Miss $458.575M Estimate
Author: Benzinga Newsdesk | August 08, 2024 07:42am
Novavax (NASDAQ:
NVAX) reported quarterly earnings of $0.99 per share which missed the analyst consensus estimate of $1.64 by 39.63 percent. The company reported quarterly sales of $415.484 million which missed the analyst consensus estimate of $458.575 million by 9.40 percent. This is a 2.11 percent decrease over sales of $424.426 million the same period last year.
Posted In: NVAX